✦ LIBER ✦

The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS study

✍ Scribed by B. I. Eriksson; G. Agnelli; A. T. Cohen; O. E. Dahl; M. R. Lassen; P. Mouret; N. Rosencher; P. Kälebo; S. Panfilov; C. Eskilson; M. Andersson; on behalf of the EXPRESS Study Group

Book ID: 109148229
Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 96 KB
Volume: 1
Category: Article
ISSN: 1538-7933
DOI: 10.1111/j.1538-7836.2003.00494.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A new oral direct thrombin inhibitor, da

A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial

✍ B. I. ERIKSSON; O. E. DAHL; H. R. BÜLLER; R. HETTIARACHCHI; N. ROSENCHER; M-L. B 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB

A phase II study of the oral factor Xa i

A phase II study of the oral factor Xa inhibitor LY517717 for the prevention of venous thromboembolism after hip or knee replacement

✍ G. AGNELLI; S. HAAS; J. S. GINSBERG; K. A. KRUEGER; A. DMITRIENKO; J. T. BRANDT 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 533 KB

Oral, direct Factor Xa inhibition with B

Oral, direct Factor Xa inhibition with BAY 59-7939 for the prevention of venous thromboembolism after total hip replacement

✍ B. I. ERIKSSON; L. BORRIS; O. E. DAHL; S. HAAS; M. V. HUISMAN; A. K. KAKKAR; F. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB

BAY 59-7939: an oral, direct Factor Xa i

BAY 59-7939: an oral, direct Factor Xa inhibitor for the prevention of venous thromboembolism in patients after total knee replacement. A phase II dose-ranging study

✍ A. G. G. TURPIE; W. D. FISHER; K. A. BAUER; L. M. KWONG; M. W. IRWIN; P. KÄLEBO; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB